打破障碍:通过微环境重塑来增强CAR-armored T细胞治疗固体瘤的疗法
Tereza Andreou1, Constantina Neophytou2, Maria Kalli1
1Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.
Frontiers in immunology
|September 19, 2025
概括
化学抗原受体 (CAR) T细胞疗法通过克服瘤微环境,对固体瘤显示出有前途. 创新的CAR T细胞设计提高了针对性和稳定性,以改善癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法是血液癌症的突破.
- 显著的挑战阻碍了CAR T细胞在固体瘤中的疗效,主要是由于瘤微环境.
- 瘤微环境创造了物理障碍和免疫抑制条件,限制了工程T细胞功能.
研究的目的:
- 审查瘤微环境中阻碍固体瘤CAR T细胞治疗的障碍.
- 讨论创新的CAR T细胞设计,以解决瘤向,稳定性和毒性问题.
- 突出重编程瘤微环境的策略,以增强CAR T细胞治疗.
主要方法:
- 关于CAR T细胞疗法的最近临床和临床前进展的综述.
- 分析瘤微环境特征及其对工程T细胞的影响.
- 讨论包括瘤和血管正常化在内的策略.
主要成果:
- 瘤微环境对CAR T细胞的透和功能构成了重要的物理和免疫抑制障碍.
- 正在开发创新的CAR T细胞设计,以提高瘤向精度和稳定性.
- 重新编程瘤微环境的策略显示了提高CAR T细胞治疗疗效的潜力.
结论:
- 克服瘤微环境对于在固体瘤中成功进行CAR T细胞治疗至关重要.
- 在CAR T细胞设计和瘤微环境调制方面的进步为患者提供了新的希望.
- 这一领域正在迅速向难以治疗的固体瘤的个性化细胞疗法发展.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


